Allogene Therapeutics Newsroom

JMP Securities Maintains Allogene Therapeutics(ALLO.US) With Hold Rating

JMP Securities analyst Reni Benjamin maintains $Allogene Therapeutics(ALLO.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 35.5% and a total average return of -6.

moomoo News01:32 ET

Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of James Hardie Industries plc (NYSE:JHX) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.James Hardie Industries posted adjuste

BenzingaMay 21 13:36 ET

Allogene Therapeutics Shares Jump 10% on Share Purchases by Chairman, CEO

By Denny Jacob Allogene Therapeutics shares jumped 10% on Tuesday after company insiders bought up shares, often an indication of confidence by leadership. Shares were trading around $2.83. The stoc

WSJMay 21 09:23 ET

Insider Trading: Allogene Therapeutics' Insider Buys Shares Worth $5M

TipRanksMay 21 08:27 ET

ASTS, ALLO and CMCM Are Among Premarket Gainers

Seeking AlphaMay 21 08:26 ET

Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Shares of Larimar Therapeutics, Inc.. (NASDAQ:LRMR) rose sharply in today's pre-market trading after the company announced that the FDA removed the partial clinical hold previously placed on the nomla

BenzingaMay 21 08:12 ET

Allogene Therapeutics Is Maintained at Outperform by Oppenheimer

Allogene Therapeutics Is Maintained at Outperform by Oppenheimer

Dow JonesMay 21 08:11 ET

Express News | Allogene : Oppenheimer Cuts Target Price to $13 From $14

ReutersMay 21 08:10 ET

Express News | Oppenheimer Maintains Outperform on Allogene Therapeutics, Lowers Price Target to $13

BenzingaMay 21 08:00 ET

Analysts Are Bullish on These Healthcare Stocks: Savara (SVRA), Allogene Therapeutics (ALLO)

TipRanksMay 21 07:50 ET

Allogene Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Allogene Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 16 07:59 ET

Express News | Allogene Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $9 From $10

ReutersMay 16 06:11 ET

Truist Securities Maintains Buy on Allogene Therapeutics, Maintains $17 Price Target

Truist Securities analyst Asthika Goonewardene maintains Allogene Therapeutics with a Buy and maintains $17 price target.

Analyst UpgradesMay 15 14:17 ET

Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket

Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.Arcutis Biotherapeutics

BenzingaMay 15 08:14 ET

Analysts Are Bullish on Top Healthcare Stocks: AdaptHealth (AHCO), Allogene Therapeutics (ALLO)

TipRanksMay 15 07:30 ET

DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Wednesday.Shares of DLocal Limited (NASDAQ:DLO) fell sharply in today's pre-market trading after

BenzingaMay 15 06:12 ET

Express News | Allogene Therapeutics Files For Offering Of Up To 37.93M Shares Of Common Stock

BenzingaMay 14 16:43 ET

Express News | Allogene Therapeutics Inc Files for Offering of up to 37.93 Mln of Common Stock - SEC Filing

ReutersMay 14 16:39 ET

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Generation Bio (GBIO)

TipRanksMay 14 08:50 ET

Express News | Allogene Therapeutics Inc : B. Riley Cuts Target Price to $7 From $10

ReutersMay 14 07:09 ET